Huntsman Cancer Institute (HCI) has a robust and highly interactive Senior Leadership team comprised of eight individuals: HCI Executive Director: Mary Beckede, PhD Senior Director of Finance and Administration: Scott Lloyd, MBA, CPA Senior Director of Basic Science: Barbara Graves, PhD Senior Director of Early Translational Research: David Jones, PhD Senior Director of Clinical Research: Sunil Sharma, MD Senior Director of Community Oncology Research: Wallace Akerley, MD Senior Director of Prevention and Outreach: Randall Burt, MD Senior Director of Clinical Affairs: Sean Mulvihill, MD Huntsman Cancer Hospital (HCH) Executive Director: Ray Lynch, MBA, CPA The Senior Leadership is responsible for strategic planning, integration, financial management, and evaluation of all three areas of the HCI mission: research, clinical care, and education/outreach. In the research arena, members of the Senior Leadership oversee CCSG Programs, Shared Resources, and Support Services such as the Protocol Review and Monitoring System. They also provide leadership regarding data and safety monitoring as well as participation of minorities and children in clinical trials. HCI Senior Leadership forms the Director's Cabinet. The Cabinet meets weekly for one to two hours with an agenda and holds a two-to-three day off-site retreat in the winter each year, as well as a multi-day spring conference to review and finalize the next year's budget. In addition, each Senior Leader meets individually with Dr. Beckerle on a regulady scheduled weekly, bi-weekly, or monthly (minimum level) calendar, depending on particular needs. The Executive Director and Senior Directors of Finance and Administration, Basic Science, Eady Translational Research, Clinical Research, Community Oncology Research, and Prevention and Outreach are members of the Research Leadership Council, which leads the direction of the Cancer Center's research Programs and support services. Section 7.1 describes the key appointments, credentials, and responsibilities of the Executive Director and each Cabinet member, which are critical to achieve the strategic goals of HCI as an NCI-Designated Cancer Center. Though not directly involved in leading the CCSG efforts, the Senior Director of Clinical Affairs and HCH Executive Director support the goals of the CCSG by overseeing clinical operations and planning as well as facilitating integration of HCI's research and clinical care missions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-24
Application #
8465104
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
24
Fiscal Year
2013
Total Cost
$95,278
Indirect Cost
$21,836
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Li, Lian; Yang, Jiyuan; Wang, Jiawei et al. (2018) Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 12:3658-3670
Wu, Yelena P; Nagelhout, Elizabeth; Aspinwall, Lisa G et al. (2018) A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma. Patient Educ Couns 101:452-459
Tiburcio, Patricia D B; Xiao, Bing; Chai, Yi et al. (2018) IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment. Oncotarget 9:35100-35113
Ferris, Elliott; Abegglen, Lisa M; Schiffman, Joshua D et al. (2018) Accelerated Evolution in Distinctive Species Reveals Candidate Elements for Clinically Relevant Traits, Including Mutation and Cancer Resistance. Cell Rep 22:2742-2755
Ou, Judy Y; Fowler, Brynn; Ding, Qian et al. (2018) A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. BMC Cancer 18:115
Liang, Wenjie; Yang, Pengfei; Huang, Rui et al. (2018) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res :
Vázquez-Arreguín, Karina; Maddox, Jessica; Kang, Jinsuk et al. (2018) BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism. Mol Cancer Res 16:439-452
Peres, Lauren C; Cushing-Haugen, Kara L; Anglesio, Michael et al. (2018) Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol 151:53-60
Zeng, Tao; Fleming, Aaron M; Ding, Yun et al. (2018) Nanopore Analysis of the 5-Guanidinohydantoin to Iminoallantoin Isomerization in Duplex DNA. J Org Chem 83:3973-3978
Himbert, Caroline; Ose, Jennifer; Nattenmüller, Johanna et al. (2018) Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study. Cancer Epidemiol Biomarkers Prev :

Showing the most recent 10 out of 1193 publications